AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
State-of-the-art strategies for the diagnosis and management of acromegaly
Authors: Klibanski, A Ho, K Freda, PU Clemmons, DR Barkan, AL Kleinberg, DL Trainer, PJ Swearingen, B Molitch, ME Wass, JAH Thorner, MO Melmed, S Strasburger, CJ Frohman, LA
Citation: A. Klibanski et al., State-of-the-art strategies for the diagnosis and management of acromegaly, ENDOCRINOLO, 11(3), 2001, pp. 223-232
Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency
Authors: Herschbach, P Henrich, G Strasburger, CJ Feldmeier, H Marin, F Attanasio, AM Blum, WF
Citation: P. Herschbach et al., Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency, EUR J ENDOC, 145(3), 2001, pp. 255-265
Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH
Authors: Maccario, M Tassone, F Gauna, C Oleandri, SE Aimaretti, G Procopio, M Grottoli, S Pflaum, CD Strasburger, CJ Ghigo, E
Citation: M. Maccario et al., Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH, EUR J ENDOC, 144(3), 2001, pp. 251-256
Acquired growth hormone resistance in patients with chronic heart failure:Implications for therapy with growth hormone
Authors: Anker, SD Volterrani, M Pflaum, CD Strasburger, CJ Osterziel, KJ Doehner, W Ranke, MB Poole-Wilson, PA Giustina, A Dietz, R Coats, AJS
Citation: Sd. Anker et al., Acquired growth hormone resistance in patients with chronic heart failure:Implications for therapy with growth hormone, J AM COL C, 38(2), 2001, pp. 443-452
Doping with growth hormone
Authors: Bidlingmaier, M Wu, Z Strasburger, CJ
Citation: M. Bidlingmaier et al., Doping with growth hormone, J PED END M, 14(8), 2001, pp. 1077-1083
Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency
Authors: Maccario, M Aimaretti, G Grottoli, S Gauna, C Tassone, F Corneli, G Rossetto, R Wu, Z Strasburger, CJ Ghigo, E
Citation: M. Maccario et al., Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency, INT J OBES, 25(8), 2001, pp. 1233-1239
Normal values of insulin-like growth factor I and their clinical utility in adults
Authors: Strasburger, CJ Bidlingmaier, M Wu, ZD Morrison, KM
Citation: Cj. Strasburger et al., Normal values of insulin-like growth factor I and their clinical utility in adults, HORMONE RES, 55, 2001, pp. 100-105
How should insulin-like growth factor I be measured? A consensus statement
Authors: Ranke, MB Feldt-Rasmussen, U Bang, P Baxter, RC Camacho-Hubner, C Clemmons, DR Juul, A Orskove, H Strasburger, CJ
Citation: Mb. Ranke et al., How should insulin-like growth factor I be measured? A consensus statement, HORMONE RES, 55, 2001, pp. 106-109
Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion
Authors: Muller, AF Janssen, JAMJL Lamberts, SWJ Bidlingmaier, M Strasburger, CJ Hofland, L van der Lely, AJ
Citation: Af. Muller et al., Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion, CLIN ENDOCR, 55(4), 2001, pp. 461-467
The exon 3-retaining and the exon 3-deleted forms of the growth hormone-binding protein (GHBP) in human serum are regulated differently
Authors: Kratzsch, J Wu, Z Kiess, W Dehmel, B Bosse-Henck, A Reuter, W Pflaum, CD Strasburger, CJ
Citation: J. Kratzsch et al., The exon 3-retaining and the exon 3-deleted forms of the growth hormone-binding protein (GHBP) in human serum are regulated differently, CLIN ENDOCR, 54(1), 2001, pp. 61-68
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
Authors: van der Lely, AJ Hutson, RK Trainer, PJ Besser, GM Barkan, AL Katznelson, L Klibanski, A Herman-Bonert, V Melmed, S Vance, ML Freda, PU Stewart, PM Friend, KE Clemmons, DR Johannsson, G Stavrou, S Cook, DM Phillips, LS Strasburger, CJ Hacker, S Zib, KA Davis, RJ Scarlett, JA Thorner, M
Citation: Aj. Van Der Lely et al., Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist, LANCET, 358(9295), 2001, pp. 1754-1759
High-dose leptin activates human leukocytes via receptor expression on monocytes
Authors: Zarkesh-Esfahani, H Pockley, G Metcalfe, RA Bidlingmaier, M Wu, ZD Ajami, A Weetman, AP Strasburger, CJ Ross, RJM
Citation: H. Zarkesh-esfahani et al., High-dose leptin activates human leukocytes via receptor expression on monocytes, J IMMUNOL, 167(8), 2001, pp. 4593-4599
Monoclonal anti-acid-labile subunit oligopeptide antibodies and their use in a two-site immunoassay for ALS measurement in humans
Authors: Stadler, S Wu, ZD Dressendorfer, RA Morrison, KM Khare, A Lee, PDK Strasburger, CJ
Citation: S. Stadler et al., Monoclonal anti-acid-labile subunit oligopeptide antibodies and their use in a two-site immunoassay for ALS measurement in humans, J IMMUNOL M, 252(1-2), 2001, pp. 73-82
Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-Peg), augments the amplitude of GH secretary bursts and elevates basal/nonpulsatile GH release in healthy women and men
Authors: Veldhuis, JD Bidlingmaier, M Anderson, SM Wu, Z Strasburger, CJ
Citation: Jd. Veldhuis et al., Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-Peg), augments the amplitude of GH secretary bursts and elevates basal/nonpulsatile GH release in healthy women and men, J CLIN END, 86(7), 2001, pp. 3304-3310
Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the growth hormone research society
Authors: Christiansen, JS Bengtsson, BA Thorner, MO Hintz, R Sonksen, PH Cohen, P Clemmons, D Strasburger, CJ Carlsson, L Tanaka, T Robinson, I Jorgensen, JO Johannson, G Clayton, PE Cowell, CT Malozowski, SN Hankinson, S Yee, D Baxter, R Swerdlow, A Rosenfeld, R Fradkin, JE Nishi, Y Monson, JP van den Berghe, G Carroll, PV Takala, J van der Lely, AJ Pollak, MN LeRoith, D Tachibana, K Kappelgaard, AM Langbakke, I Lippe, B Wilton, P Stein, P Salazar, DE Maneatis, T Blethen, SL Cutler, GB Blum, WF Svanberg, E Gertner, JM Shimatsu, A Takahashi, H
Citation: Js. Christiansen et al., Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the growth hormone research society, J CLIN END, 86(5), 2001, pp. 1868-1870
Changes in non-22-kilodalton (kDa) isoforms of growth hormone (GH) after administration of 22-kDa recombinant human GH in trained adult males
Authors: Wallace, JD Cuneo, RC Bidlingmaier, M Lundberg, PA Carlsson, L Boguszewski, CL Hay, J Boroujerdi, M Cittadini, A Dall, R Rosen, T Strasburger, CJ
Citation: Jd. Wallace et al., Changes in non-22-kilodalton (kDa) isoforms of growth hormone (GH) after administration of 22-kDa recombinant human GH in trained adult males, J CLIN END, 86(4), 2001, pp. 1731-1737
Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistance
Authors: Muller, AF Janssen, JA Hofland, LJ Lamberts, SW Bidlingmaier, M Strasburger, CJ van der Lely, AJ
Citation: Af. Muller et al., Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistance, J CLIN END, 86(2), 2001, pp. 590-593
Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion
Authors: Arlt, W Callies, F Koehler, I van Vlijmen, JC Fassnacht, M Strasburger, CJ Seibel, MJ Huebler, D Ernst, M Oettel, M Reincke, M Schulte, HM Allolio, B
Citation: W. Arlt et al., Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion, J CLIN END, 86(10), 2001, pp. 4686-4692
The response of molecular isoforms of growth hormone to acute exercise in trained adult males
Authors: Wallace, JD Cuneo, RC Bidlingmaier, M Lundberg, PA Carlsson, L Boguszewski, CL Hay, J Healy, ML Napoli, R Dall, R Rosen, T Strasburger, CJ
Citation: Jd. Wallace et al., The response of molecular isoforms of growth hormone to acute exercise in trained adult males, J CLIN END, 86(1), 2001, pp. 200-206
Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors
Authors: Maamra, M Bidlingmaier, M Postel-Vinay, MC Wu, Z Strasburger, CJ Ross, RJM
Citation: M. Maamra et al., Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors, ENDOCRINOL, 142(10), 2001, pp. 4389-4393
The growth hormone axis in cachectic patients with chronic heart failure: Evidence for acquired growth hormone resistance.
Authors: Anker, SD Pfaum, CD Cicoira, M Strasburger, CJ
Citation: Sd. Anker et al., The growth hormone axis in cachectic patients with chronic heart failure: Evidence for acquired growth hormone resistance., ENDOC UPD S, 9, 2001, pp. 67-79
Test method: GH
Authors: Bidlingmaier, M Wu, ZD Strasburger, CJ
Citation: M. Bidlingmaier et al., Test method: GH, BEST PRAC R, 14(1), 2000, pp. 99-109
Effects of growth hormone replacement therapy on levels of cortisol and cortisol-binding globulin in hypopituitary adults
Authors: Tschop, M Lahner, H Feldmeier, H Grasberger, H Morrison, KM Janssen, OE Attanasio, AF Strasburger, CJ
Citation: M. Tschop et al., Effects of growth hormone replacement therapy on levels of cortisol and cortisol-binding globulin in hypopituitary adults, EUR J ENDOC, 143(6), 2000, pp. 769-773
Influence of hypobaric hypoxia on leptin levels in men
Authors: Tschop, M Strasburger, CJ Topfer, M Hautmann, H Riepl, R Fischer, R Hartmann, G Morrison, K Appenzeller, M Hildebrandt, W Biollaz, J Bartsch, P
Citation: M. Tschop et al., Influence of hypobaric hypoxia on leptin levels in men, INT J OBES, 24, 2000, pp. S151-S151
Short-term fasting abolishes the sex-related difference in GH and leptin secretion in humans
Authors: Maccario, M Aimaretti, G Corneli, G Gauna, C Grottoli, S Bidlingmaier, M Strasburger, CJ Dieguez, C Casanueva, FF Ghigo, E
Citation: M. Maccario et al., Short-term fasting abolishes the sex-related difference in GH and leptin secretion in humans, AM J P-ENDO, 279(2), 2000, pp. E411-E416
Risultati: 1-25 | 26-39